Abstract: Disclosed herein is a solid oral dosage form comprising bromocriptine and one or more pharmaceutically acceptable excipients. The oral dosage form has a dissolution rate in excess of 90% in 5 minutes in 500 ml of 0.1N HCl aqueous medium at 37 C and is useful for adjusting the plasma prolactin profile of a patient.

Abstract: An articulated control surface is provided for hydrodynamic control utilig a moldable control surface. The central surface is shaped by contracting and elongating wire bundles fabricated with shape-memory alloys located in an adjacent cooling chamber. The shape-memory alloys contract when heated via an applied electric current and elongate when cooled, i.e., the electric current is removed. A pair of wire bundles is anchored inside the cooling chamber. Each bundle is routed over several pulleys in such a manner that a lateral movement is produced at the actuator end of the wire. A pair of bundles act in opposition to maintain dynamic tension at the actuator end. Cooling flow to opposing wire bundles is controlled independently to enhance response time and reduce power requirements. The actuator is a post extending from the cooling chamber to the trailing edge structure of the control surface.